/

Empresas

Or

No verificado

Orca Bio

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaOncologíaSalud

20 Comunicados de prensa

Ver todos los comunicados de prensa

28/04/2026

Industria

Oncología

Higiene alimentaria

Salud

Medicina - Varios

Farmacéutica

Biotecnología

Orca Bio Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Orca-Q® for the Treatment of High-Risk Hematologic Malignancies

Fuente

Editor

1.00

0

01/04/2026

Industria

Biotecnología

Farmacéutica

Salud

Oncología

Orca Bio Announces FDA Review Extension of BLA for Orca-T for the Treatment of Hematologic Malignancies

Fuente

Editor

1.00

0

02/03/2026

Eventos

Industria

Oncología

Salud

Biotecnología

Sanidad

Medicina - Varios

Farmacéutica

Orca Bio to Present Clinical Data on Its Pipeline of High-Precision Cell Therapies at the 52nd Annual Meeting of the EBMT

Fuente

Editor

1.00

0

05/02/2026

Biotecnología

Farmacéutica

Salud

Oncología

Industria

Orca Bio Presents New Data at the 2026 Tandem Meetings of ASTCT® and CIBMTR® Reinforcing Orca-T® as a Durable, High-Precision Cell Therapy for Hematological Malignancies

Fuente

Editor

1.00

0

21/01/2026

Ciencia

Biología

Biotecnología

Farmacéutica

Oncología

Salud

Medicina - Varios

Eventos

Industria

Orca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 2026 Tandem Meetings of ASTCT® and CIBMTR®

Fuente

Editor

1.00

0

09/01/2026

Oncología

Salud

Biología

Sanidad

Farmacéutica

Biotecnología

Orca Bio Announces $250M in Aggregate Financing in Preparation for Potential Commercialization

Fuente

Editor

1.00

0

05/01/2026

Eventos

Web y redes sociales

Salud

Biología

Farmacéutica

Oncología

Orca Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference

Fuente

Editor

1.00

0

15/12/2025

Industria

Oncología

Salud

Biología

Medicina - Varios

Farmacéutica

Biotecnología

Orca Bio Announces Orca-T® Phase 3 Data Published in Blood Demonstrate Significant Improvement in Survival Free from Chronic Graft versus Host Disease in Patients with Hematological Malignancies

Fuente

Editor

1.00

0

08/12/2025

Industria

Biotecnología

Salud

Farmacéutica

Medicina - Varios

Oncología

Orca Bio Presents New Clinical Data on its Pipeline of High-Precision Cell Therapies including Orca-Q® Without GvHD Prophylaxis and Orca-T/CAR-T Combination Therapy at the 67th ASH Annual Meeting

Fuente

Editor

1.00

0

06/12/2025

Eventos

Ferias y Congresos

Industria

Ciencia

Biotecnología

Medicina - Varios

Biología

Sanidad

Farmacéutica

Salud

Oncología

Orca Bio Presents New Clinical Data on Orca-T® in Older Patients Using Reduced Intensity Conditioning Plus New Analyses from the Precision-T Phase 3 Study at the 67th ASH Annual Meeting

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0